Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy

Weller, Roy O., Boche, Delphine, Nicoll, James A. R. · 2009 · Acta Neuropathologica

Abstract

The introduction of immunotherapy and its ultimate success will require re-evaluation of the pathogenesis of Alzheimer's disease particularly with regard to the role of the ageing microvasculature and the effects of APOE genotype. Arteries in the brain have two major functions (a) delivery of blood and (b) elimination of interstitial fluid and solutes, including amyloid-beta (Abeta), along perivascular pathways (lymphatic drainage). Both these functions fail with age and particularly severely in Alzheimer's disease and vascular dementia. Accumulation of Abeta as plaques in brain parenchyma and artery walls as cerebral amyloid angiopathy (CAA) is associated with failure of perivascular elimination of Abeta from the brain in the elderly and in Alzheimer's disease. High levels of soluble Abeta in the brain correlate with cognitive decline in Alzheimer's disease and reflect the failure of perivascular drainage of solutes from the brain and loss of homeostasis of the neuronal environment. Clinically and pathologically, there is a spectrum of disease related to functional failure of the ageing microvasculature with "pure" Alzheimer's disease at one end of the spectrum and vascular dementia at the other end. Changes in the cerebral microvasculature with age have a potential impact on therapy with cholinesterase inhibitors and especially on immunotherapy that removes Abeta from plaques in the brain, but results in an increase in severity of CAA and no clear improvement in cognition. Drainage of Abeta along perivascular pathways in ageing artery walls may need to be improved to maximise the potential for improvement of cognitive function with immunotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00401-009-0498-z

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Research works printed but not linked: 1

  1. Poirier J, Derouesne C (1985) Le concept de lacune cerebrale de 1838 a nos jours. Rev Neurol 141:3–17

Cited by

See all 300

Metadata

Authors
Weller, R. O., Boche, D., & Nicoll, J. A. R.
Affiliations
Southampton General Hospital (GB)
Corresponding author
Weller, Roy O.
Venue
Acta Neuropathologica
Published
2009-02-22
Volume
118
Issue
1
Pages
87-102
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2128307173
Cited by
297
References
101
Citations by year
2026: 4 · 2025: 10 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 11 · 2020: 20 · 2019: 13 · 2018: 23 · 2017: 15 · 2016: 16 · 2015: 23 · 2014: 27 · 2013: 24 · 2012: 17
FWCI
2.59
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
Funders
  • University of Southampton
  • Chinese Academy of Agricultural Sciences
  • Medical Research Council
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
Alzheimer's disease, cerebral amyloid angiopathy, cerebral microvasculature, aging, amyloid-beta, APOE genotype, immunotherapy, cholinesterase inhibitors, vascular dementia, cognitive decline, amyloid plaques
MeSH terms
Aging, Alzheimer Disease, Animals, Brain, Cholinesterase Inhibitors, Humans, Dementia, Vascular, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. https://app.cochat.ai/papers/10.1007/s00401-009-0498-z
The paper
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009). Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathologica. https://doi.org/10.1007/s00401-009-0498-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.